Q4 2024 · 13F-HR
Catalio Capital Management, LPholdings as filed
Filed 2025-02-14 · accession 0001958125-25-000002
$457.1M
Reported value
33
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 075887109 | BDX | BECTON DICKINSON & CO | $33.7M | 7.38% | 148,615 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $29.7M | 6.49% | 215,587 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $28.2M | 6.18% | 499,151 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $27.6M | 6.04% | 764,668 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $24.8M | 5.43% | 284,654 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $24.7M | 5.40% | 333,144 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $24.7M | 5.39% | 898,458 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $23.7M | 5.19% | 512,447 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $23.5M | 5.13% | 1,024,245 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $21.5M | 4.71% | 457,587 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $19.7M | 4.30% | 1,019,529 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $19.4M | 4.25% | 490,547 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $19.3M | 4.21% | 36,910 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $17.4M | 3.80% | 309,103 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $16.6M | 3.64% | 763,471 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $15.9M | 3.48% | 901,973 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $15.4M | 3.38% | 569,395 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $14.4M | 3.16% | 87,377 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $11.4M | 2.49% | 179,815 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $8.8M | 1.92% | 512,724 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $6.8M | 1.48% | 132,545 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $6.5M | 1.42% | 72,925 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $6.4M | 1.41% | 407,292 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $5.7M | 1.26% | 1,088,691 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $2.4M | 0.53% | 1,705,036 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $2.2M | 0.48% | 586,909 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $1.9M | 0.42% | 528,993 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $1.6M | 0.35% | 2,334,375 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $1.5M | 0.34% | 187,184 | Common | SOLE |
| 44916K106 | HYPR | HYPERFINE INC | $668,831 | 0.15% | 760,035 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $441,326 | 0.10% | 214,236 | Common | SOLE |
| N0731H103 | ATAI | ATAI LIFE SCIENCES NV | $261,821 | 0.06% | 196,858 | Common | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $144,273 | 0.03% | 294,374 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.